Literature DB >> 2456316

Diagnosis of Lafora disease by skin biopsy.

J W White1, M R Gomez.   

Abstract

The Lafora type of progressive myoclonus epilepsy is a rare and fatal familial disease characterized by seizures, myoclonus, and dementia. This diagnosis was confirmed in 2 patients by demonstrating the presence of intracytoplasmic polyglucosan bodies, or Lafora bodies, in the peripheral portion of the eccrine sweat gland duct. Exclusive use of the periodic acid-Schiff stain is recommended for demonstrating these diagnostic inclusions. Electron microscopy reveals fine pale-staining filaments, fine dark-staining granules, and dark-rimmed vacuoles within these non-membrane-bound inclusions. Skin biopsy is the preferred method of confirming the diagnosis of Lafora disease.

Entities:  

Mesh:

Substances:

Year:  1988        PMID: 2456316     DOI: 10.1111/j.1600-0560.1988.tb00538.x

Source DB:  PubMed          Journal:  J Cutan Pathol        ISSN: 0303-6987            Impact factor:   1.587


  2 in total

1.  Diagnosis by axilla skin biopsy in an early case of Lafora's disease.

Authors:  G Rubio; C Garcia Guijo; J J Mallada; A Cabello; A Garcia Merino
Journal:  J Neurol Neurosurg Psychiatry       Date:  1992-11       Impact factor: 10.154

2.  Role of levetiracetam in refractory seizures due to a rare progressive myoclonic epilepsy: Lafora body disease.

Authors:  Mubashira Hashmi; Feroza Saleem; Muhammad Shahid Mustafa; Mughis Sheerani; Zeeshan Ehtesham; Khurram Siddiqui
Journal:  BMJ Case Rep       Date:  2010-11-05
  2 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.